Aldeyra Therapeutics, INC. (ALDX) SEC Filings — 2025
18 SEC filings for Aldeyra Therapeutics, INC. (ALDX) in 2025.
Filings
- Aldeyra Therapeutics Announces Board and Compensation Changes — 8-K · Dec 31, 2025
- Aldeyra Therapeutics, INC. 8-K Filing — 8-K · Dec 16, 2025
- Aldeyra Therapeutics, INC. 8-K Filing — 8-K · Nov 13, 2025
- Aldeyra Narrows Q3 Loss by 49% on Steep R&D Cuts — 10-Q · Nov 5, 2025
- Aldeyra Therapeutics Files 8-K — 8-K · Oct 28, 2025
- Aldeyra Therapeutics Files 8-K — 8-K · Aug 19, 2025
- Aldeyra Narrows Q2 Loss to $20.1M Amid Reproxalap Review — 10-Q · Aug 7, 2025
- Aldeyra Therapeutics Files 8-K Report — 8-K · Jul 17, 2025
- Aldeyra Therapeutics Files 8-K — 8-K · Jun 26, 2025
- Aldeyra Therapeutics Files 8-K — 8-K · Jun 17, 2025
- Aldeyra Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 11, 2025
- Aldeyra Therapeutics Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Aldeyra Therapeutics Files 8-K — 8-K · May 6, 2025
- Aldeyra Therapeutics Files DEF 14A on Executive Compensation — DEF 14A · Apr 25, 2025
- Aldeyra Therapeutics Announces Board and Executive Changes — 8-K · Apr 17, 2025
- Aldeyra Therapeutics Files 8-K — 8-K · Apr 3, 2025
- Aldeyra Therapeutics Files 2024 Annual Report Amendment — 10-K/A · Mar 28, 2025
- Aldeyra Therapeutics Files 2024 10-K — 10-K · Feb 28, 2025